FAST: Fast, free, consistent, and unsupervised oligodendrocyte segmentation and tracking system
To develop reparative therapies for neurological disorders like multiple sclerosis (MS), we need to better understand the physiology of loss and replacement of oligodendrocytes, the cells that make myelin and are the target of damage in MS. In vivo two-photon fluorescence microscopy allows direct vi...
Saved in:
| Published in | eNeuro Vol. 12; no. 2; p. ENEURO.0025-24.2024 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Society for Neuroscience
01.02.2025
|
| Subjects | |
| Online Access | Get full text |
| ISSN | 2373-2822 2373-2822 |
| DOI | 10.1523/ENEURO.0025-24.2024 |
Cover
| Summary: | To develop reparative therapies for neurological disorders like multiple sclerosis (MS), we need to better understand the physiology of loss and replacement of oligodendrocytes, the cells that make myelin and are the target of damage in MS. In vivo two-photon fluorescence microscopy allows direct visualization of oligodendrocytes in the intact brain of transgenic mouse models, promising a deeper understanding of the longitudinal dynamics of replacing oligodendrocytes after damage. However, the task of tracking the fate of individual oligodendrocytes requires extensive effort for manual annotation and is especially challenging in three-dimensional images. While several models exist for annotating cells in two-dimensional images, few models exist to annotate cells in three-dimensional images and even fewer are designed for tracking cells in longitudinal imaging. Notably, existing options often come with a substantial financial investment, being predominantly commercial or confined to proprietary software. Furthermore, the complexity of processes and myelin formed by individual oligodendrocytes can result in the failure of algorithms that are specifically designed for tracking cell bodies alone. Here, we propose a fast, free, consistent, and unsupervised beta-mixture oligodendrocyte segmentation system (FAST) that is written in open-source software, and can segment and track oligodendrocytes in three-dimensional images over time with minimal human input. We showed that the FAST model can segment and track oligodendrocytes similarly to a blinded human observer. Although FAST was developed to apply to our studies on oligodendrocytes, we anticipate that it can be modified to study four-dimensional in vivo data of any brain cell with associated complex processes.
Significance Statement
We have developed “FAST: Fast, free, consistent, and unsupervised oligodendrocyte segmentation and tracking system” to solve our challenge of quantification of four-dimensional data acquired from longitudinal in vivo imaging. Although it was developed for oligodendrocytes, we will make the code entirely open source and user-friendly, and expect that it will be useful for segmentation for any cell body from a complex cell amenable to longitudinal in vivo imaging. |
|---|---|
| Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 JOM is a principal investigator on sponsored research projects by Vigil Neurosciences, receives grant support from the National MS Society, the federal government and the Hilton Foundation, and research support from Linda Pechanik Montague Investigator Award and the Fishman Foundation. RTS receives consulting income from Octave Bioscience and compensation for scientific review duties from the American Medical Association and the federal government. The authors declare no competing financial interests. These authors contributed equally. This research was supported by R01NS085211, R21NS093349, R01NS112274 and R01NS060910 from the National Institutes Health. Author Contributions: E.B., J.L.O-M., and R.T.S. designed research; E.B., G.E.P., J.L.O-M., and R.T.S. performed research; E.B., V.G., J.L.O-M., and R.T.S. contributed unpublished reagents/analytic tools; E.B., G.E.P., and V.G. analyzed data; E.B., G.E.P., J.L.O-M., and R.T.S. wrote the paper. |
| ISSN: | 2373-2822 2373-2822 |
| DOI: | 10.1523/ENEURO.0025-24.2024 |